All News

In the United States, nearly 50 million Americans suffer from migraine, the majority of whom are between 25 to 55 years of age. The costs of treating this large population have been estimated to be $22 billion annually. A new report, published by the Pharmacy Benefit Management Institute, found that direct healthcare costs for patients with migraine were estimated at $2571 higher than those for similar patients who don’t experience migraine.

According to findings from a preliminary study, researchers now believe that multiple sclerosis (MS) may not flare following pregnancy as had long been assumed. The study results will be presented at the American Academy of Neurology’s 71st Annual Meeting in Philadelphia, Pennsylvania, May 4-10, 2019.

While Alzheimer disease and other brain diseases are similar and cannot be stopped, it's important that families get the right diagnosis in order to get the best care and plan for the future; daily consumption of eggs has been found to slightly increase the risk of heart disease and early mortality; Maine Governor Janet Mills submitted a bill to allow abortions to be performed by medical professionals besides physicians.

A compressed vaccine schedule for older adults could help increase uptake and decrease the impact of the influenza vaccine’s waning effectiveness as months go by, but such a schedule would not be beneficial if flu season peaks early or if a compressed schedule results in a decrease in vaccine uptake.

The March issue of The American Journal of Managed Care® (AJMC®) featured research on immuno-oncology costs and Medicare Annual Wellness Visits in addition to studies on the issue’s theme of Medicaid. Here are 5 findings from research published in the issue.

This week, the top managed care news included the 2020 budget plan proposing a mix of healthcare spending cuts and increases; the FDA approving the first immunotherapy regimen for breast cancer; and researchers uncovering how sodium glucose co-transporter-2 inhibitors work.

The industry is speedily moving and advancing, and the only way for hospitals see continued success is if they stay nimble and capable of adapting to new developments. Looking to the future, healthcare systems should concern themselves less with size and instead shift focus to adopting business and payment models that bring value.

The European Headache Federation (EHF) recently sought to create an expert- and evidence-based guideline for the treatment of migraine with monoclonal antibodies that target the calcitonin gene-related peptide (CGRP). However, in reviewing available research, the EHF found that there was not enough evidence to provide a guideline based on the Grading of Recommendation, Assessment, Development, and Evaluation approach.

Brand Logo

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo